Full text not available from this repository.

Abstract

OA is a chronic, progressive and disabling joint disease, leading to a poor quality of life and an enormous social and economic burden. Current therapies for OA patients remain limited, which creates an area of huge unmet medical need. For some time, researchers have been looking for approaches that can inhibit the structural progression of OA. A variety of potential disease-modifying OA drugs have been developed, targeting cartilage, inflammatory pathways or subchondral bone. In addition, non-pharmacological therapies, including joint distraction and weight loss, draw increasing attention, with some showing disease-modifying potential. Thus we performed a comprehensive review to discuss the current status of disease-modifying therapies in OA and appraise the potentials of emerging novel agents.

Item Type:	Article
Authors/Creators:	Huang, Z and Ding, C and Li, T and Yu, SP
Keywords:	cartilage, disease-modifying osteoarthritis drugs, non-pharmacological treatments, osteoarthritis, therapeutic targets
Journal or Publication Title:	Rheumatology
Publisher:	Oxford Univ Press
ISSN:	1462-0324
DOI / ID Number:	https://doi.org/10.1093/rheumatology/kex496
Copyright Information:	Copyright 2017 The Author
Related URLs:	Google Scholar: Ding, C UTAS Profile: Ding, C
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page